4-(Bromomethyl)-2-methoxypyridine hydrobromide, 98%, 100mg

1,3-Dibromoazulene>98.0%(GC)200mg

4-(2-Methylthiazol-4-yl)-1H-pyrrole-2-carboxylic acid, 95.0%, 1g

1-(2-Chloroethyl)-1H-1,2,4-triazole, 95.0%, 1g

n-(4-Formyl-1,3-thiazol-2-yl)-n-(4-methoxyphenyl)acetamide, 97%, 250mg

1-(Naphthalen-2-yl)-2,5-dihydro-1H-pyrrole-2,5-dione, 97%, 100mg

3-(Difluoromethyl)pyrazine-2-carboxylic acid, 98%, 250mg

3-Benzofurancarboxylic acid, 4-[(1E)-3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-, (2S,3S)-, 95%, 250mg

1-(2-Methylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

Rutine trihydratée, min.95%, Ph.Eur., 100 g, emballage plastique.

Dichlorobis(trimethylphosphine)nickel(II), 98%, 250mg

[Bis(phenylsulfanyl)methyl]benzene, 5g

Tert-butyln-(3-formylcyclobutyl)carbamate, 98%, 1g